Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sienna Biopharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sienna Biopharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Sienna Biopharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is SNNA. The reporting company's CIK number is 1656328.
The total value of stock buying since 2005 is $964,697.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-09-18||Fenton Dennis M||Buy||1,250||22.96||28,697|
|2017-08-01||Andrews Timothy K. (General Counsel & Secretary)||Buy||15,000||15.00||225,000|
|2017-08-01||Lizzul Paul F. (Chief Medical Officer)||Buy||10,000||15.00||150,000|
|2017-08-01||Stroehmann Diane (See Remarks)||Buy||7,000||15.00||105,000|
|2017-08-01||Peterson Richard D (Chief Financial Officer)||Buy||7,000||15.00||105,000|
|2017-08-01||Leonard Keith R||Buy||16,700||15.00||250,500|
|2017-08-01||Mast Erle T||Buy||6,700||15.00||100,500|
Insider trading activities including stock purchases, stock sales, and option exercises of SNNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sienna Biopharmaceuticals, Inc. (symbol SNNA, CIK number 1656328) see the Securities and Exchange Commission (SEC) website.